Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v2-FR
Language English French
Date Updated 2024-05-04 2023-02-06
Drug Identification Number 02495066 02495066
Brand name JAMP IMATINIB JAMP IMATINIB
Common or Proper name Imatinib mesylate Imatinib mesylate
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients IMATINIB IMATINIB
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 12x10 12x10
ATC code L01EA L01EA
ATC description
Reason for shortage Other (Please describe in comments) Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-02-06 2023-02-06
Estimated end date 2025-12-31 2023-03-10
Actual end date 2024-05-03
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Bottle available
Health Canada comments